Jonathan Florentin1, Yi-Yin Tai1, Thomas Bertero2, Partha Dutta1,3, Stephen Y Chan1,3, Jingsi Zhao1, Stéphanie Torrino2, Lee Ohayon1, Tomasz Brzoska1, Ying Tang1, Jimin Yang1, Vinny Negi1, Chen-Shan Chen Woodcock1, Michael G Risbano1,4, Seyed Mehdi Nouraie1,4, Prithu Sundd1,4. 1. Center for Pulmonary Vascular Biology and Medicine, Pittsburgh Heart, Lung, Blood Vascular Medicine Institute (J.Z., J.F., Y.-Y.T., L.O., T. Brzoska, Y.T., J.Y., V.N., C.-S.C.W., M.G.R., S.M.N., P.S., P.D., S.Y.C.), University of Pittsburgh School of Medicine and UPMC, Pittsburgh, PA. 2. Université Côte d'Azur, CNRS, IPMC, Valbonne, France (S.T., T. Bertero). 3. Division of Cardiology, Department of Medicine (P.D., S.Y.C.), University of Pittsburgh School of Medicine and UPMC, Pittsburgh, PA. 4. Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine (M.G.R., S.M.N., P.S.), University of Pittsburgh School of Medicine and UPMC, Pittsburgh, PA.
Abstract
RATIONALE: Unproven theories abound regarding the long-range uptake and endocrine activity of extracellular blood-borne microRNAs into tissue. In pulmonary hypertension (PH), microRNA-210 (miR-210) in pulmonary endothelial cells promotes disease, but its activity as an extracellular molecule is incompletely defined. OBJECTIVE: We investigated whether chronic and endogenous endocrine delivery of extracellular miR-210 to pulmonary vascular endothelial cells promotes PH. METHODS AND RESULTS: Using miR-210 replete (wild-type [WT]) and knockout mice, we tracked blood-borne miR-210 using bone marrow transplantation and parabiosis (conjoining of circulatory systems). With bone marrow transplantation, circulating miR-210 was derived predominantly from bone marrow. Via parabiosis during chronic hypoxia to induce miR-210 production and PH, miR-210 was undetectable in knockout-knockout mice pairs. However, in plasma and lung endothelium, but not smooth muscle or adventitia, miR-210 was observed in knockout mice of WT-knockout pairs. This was accompanied by downregulation of miR-210 targets ISCU (iron-sulfur assembly proteins)1/2 and COX10 (cytochrome c oxidase assembly protein-10), indicating endothelial import of functional miR-210. Via hemodynamic and histological indices, knockout-knockout pairs were protected from PH, whereas knockout mice in WT-knockout pairs developed PH. In particular, pulmonary vascular engraftment of miR-210-positive interstitial lung macrophages was observed in knockout mice of WT-knockout pairs. To address whether engrafted miR-210-positive myeloid or lymphoid cells contribute to paracrine miR-210 delivery, we studied miR-210 knockout mice parabiosed with miR-210 WT; Cx3cr1 knockout mice (deficient in myeloid recruitment) or miR-210 WT; Rag1 knockout mice (deficient in lymphocytes). In both pairs, miR-210 knockout mice still displayed miR-210 delivery and PH, thus demonstrating a pathogenic endocrine delivery of extracellular miR-210. CONCLUSIONS: Endogenous blood-borne transport of miR-210 into pulmonary vascular endothelial cells promotes PH, offering fundamental insight into the systemic physiology of microRNA activity. These results also describe a platform for RNA-mediated crosstalk in PH, providing an impetus for developing blood-based miR-210 technologies for diagnosis and therapy in this disease.
RATIONALE: Unproven theories abound regarding the long-range uptake and endocrine activity of extracellular blood-borne microRNAs into tissue. In pulmonary hypertension (PH), microRNA-210 (miR-210) in pulmonary endothelial cells promotes disease, but its activity as an extracellular molecule is incompletely defined. OBJECTIVE: We investigated whether chronic and endogenous endocrine delivery of extracellular miR-210 to pulmonary vascular endothelial cells promotes PH. METHODS AND RESULTS: Using miR-210 replete (wild-type [WT]) and knockout mice, we tracked blood-borne miR-210 using bone marrow transplantation and parabiosis (conjoining of circulatory systems). With bone marrow transplantation, circulating miR-210 was derived predominantly from bone marrow. Via parabiosis during chronic hypoxia to induce miR-210 production and PH, miR-210 was undetectable in knockout-knockout mice pairs. However, in plasma and lung endothelium, but not smooth muscle or adventitia, miR-210 was observed in knockout mice of WT-knockout pairs. This was accompanied by downregulation of miR-210 targets ISCU (iron-sulfur assembly proteins)1/2 and COX10 (cytochrome c oxidase assembly protein-10), indicating endothelial import of functional miR-210. Via hemodynamic and histological indices, knockout-knockout pairs were protected from PH, whereas knockout mice in WT-knockout pairs developed PH. In particular, pulmonary vascular engraftment of miR-210-positive interstitial lung macrophages was observed in knockout mice of WT-knockout pairs. To address whether engrafted miR-210-positive myeloid or lymphoid cells contribute to paracrine miR-210 delivery, we studied miR-210 knockout mice parabiosed with miR-210 WT; Cx3cr1 knockout mice (deficient in myeloid recruitment) or miR-210 WT; Rag1 knockout mice (deficient in lymphocytes). In both pairs, miR-210 knockout mice still displayed miR-210 delivery and PH, thus demonstrating a pathogenic endocrine delivery of extracellular miR-210. CONCLUSIONS: Endogenous blood-borne transport of miR-210 into pulmonary vascular endothelial cells promotes PH, offering fundamental insight into the systemic physiology of microRNA activity. These results also describe a platform for RNA-mediated crosstalk in PH, providing an impetus for developing blood-based miR-210 technologies for diagnosis and therapy in this disease.
Authors: Sathish Babu Vasamsetti; Jonathan Florentin; Emilie Coppin; Lotte C A Stiekema; Kang H Zheng; Muhammad Umer Nisar; John Sembrat; David J Levinthal; Mauricio Rojas; Erik S G Stroes; Kang Kim; Partha Dutta Journal: Immunity Date: 2018-06-26 Impact factor: 31.745
Authors: Makon-Sébastien Njock; Henry S Cheng; Lan T Dang; Maliheh Nazari-Jahantigh; Andrew C Lau; Emilie Boudreau; Mark Roufaiel; Myron I Cybulsky; Andreas Schober; Jason E Fish Journal: Blood Date: 2015-04-02 Impact factor: 22.113
Authors: Chung Ho Leung; Lixing Wang; Jan M Nielsen; Michael B Tropak; Yana Y Fu; Hideyuki Kato; John Callahan; Andrew N Redington; Christopher A Caldarone Journal: Cardiovasc Drugs Ther Date: 2014-02 Impact factor: 3.727
Authors: Jason D Arroyo; John R Chevillet; Evan M Kroh; Ingrid K Ruf; Colin C Pritchard; Donald F Gibson; Patrick S Mitchell; Christopher F Bennett; Era L Pogosova-Agadjanyan; Derek L Stirewalt; Jonathan F Tait; Muneesh Tewari Journal: Proc Natl Acad Sci U S A Date: 2011-03-07 Impact factor: 11.205
Authors: Lixing Wang; Norihiko Oka; Michael Tropak; John Callahan; John Lee; Greg Wilson; Andrew Redington; Christopher A Caldarone Journal: J Thorac Cardiovasc Surg Date: 2008-06-02 Impact factor: 5.209
Authors: Germana Zaccagnini; Fabio Martelli; Pasquale Fasanaro; Alessandra Magenta; Carlo Gaetano; Anna Di Carlo; Paolo Biglioli; Marco Giorgio; Ines Martin-Padura; Pier Giuseppe Pelicci; Maurizio C Capogrossi Journal: Circulation Date: 2004-06-01 Impact factor: 29.690
Authors: Haopeng Wang; Henrik Flach; Michio Onizawa; Lai Wei; Michael T McManus; Arthur Weiss Journal: Nat Immunol Date: 2014-03-09 Impact factor: 25.606
Authors: Rahul Kumar; Claudia Mickael; Biruk Kassa; Liya Gebreab; Jeffrey C Robinson; Daniel E Koyanagi; Linda Sanders; Lea Barthel; Christina Meadows; Daniel Fox; David Irwin; Min Li; B Alexandre McKeon; Suzette Riddle; R Dale Brown; Leslie E Morgan; Christopher M Evans; Daniel Hernandez-Saavedra; Angela Bandeira; James P Maloney; Todd M Bull; William J Janssen; Kurt R Stenmark; Rubin M Tuder; Brian B Graham Journal: Nat Commun Date: 2017-05-30 Impact factor: 14.919
Authors: Vinny Negi; Jimin Yang; Gil Speyer; Andres Pulgarin; Adam Handen; Jingsi Zhao; Yi Yin Tai; Ying Tang; Miranda K Culley; Qiujun Yu; Patricia Forsythe; Anastasia Gorelova; Annie M Watson; Yassmin Al Aaraj; Taijyu Satoh; Maryam Sharifi-Sanjani; Arun Rajaratnam; John Sembrat; Steeve Provencher; Xianglin Yin; Sara O Vargas; Mauricio Rojas; Sébastien Bonnet; Stephanie Torrino; Bridget K Wagner; Stuart L Schreiber; Mingji Dai; Thomas Bertero; Imad Al Ghouleh; Seungchan Kim; Stephen Y Chan Journal: Sci Adv Date: 2021-10-20 Impact factor: 14.136
Authors: Rachel E Powell; Yi Yin Tai; Jason N Kennedy; Christopher W Seymour; Stephen Y Chan Journal: J Transl Med Date: 2022-10-04 Impact factor: 8.440